TITLE

Jubilant net profit up 31.7%

PUB. DATE
May 2006
SOURCE
Chemical Business;May2006, Vol. 20 Issue 5, p70
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the increase in the net profit of Jubilant Organosys for the fourth quarter of 2005 to 2006. Increase in the company's net sales; Growth of the pharmaceuticals and life science chemicals; Approval of a proposal to raise funds through private placement of shares.
ACCESSION #
21279463

 

Related Articles

  • Jubilant Q2 profits double on higher sales.  // Chemical Business;Nov2007, Vol. 21 Issue 11, p76 

    The article reports on the increase in net profits of Jubilant Organosys, the pharmaceutical and Custom Research and Manufacturing Services (CRAMS) company in India, for the second quarter ended September 30, 2007. There was an almost 33% increase in the consolidated net sales of Jubilant. Half...

  • Jubilant Focuses on Growth from Regulated Markets in Europe and the U.S. Ramesh, Deepti // Chemical Week;9/19/2007, Vol. 169 Issue 30, p42 

    The article reports on the statement issued by Jubilant Organosys that the regulated markets of Europe and the U.S. are among its priorities and that it expects substantial growth in international sales. The company's international sales for first-quarter 2008, which runs from April-June 2007,...

  • Forex losses eat into Jubilant's margins.  // Chemical Business;May2008, Vol. 22 Issue 5, p59 

    The article reports on a drop in fourth quarter 2008 profit posted by Indian pharmaceutical company Jubilant Organosys Ltd., due to foreign exchange losses. The company reported an 8.8 per cent year-on-year drop in fourth-quarter net profit. The company recorded a foreign exchange loss of Rs...

  • Custom Manufacturers' Results Improve. Scott, Alex // Chemical Week;8/10/2005, Vol. 167 Issue 26, p29 

    Focuses on several manufacturers of custom pharmaceutical intermediates that posted improvements in sales and earnings in their financial reports as of August 10, 2005. Lonza; Cambrex; Hovione; Jubilant Organysis.

  • Jubilant focuses on life sciences. Hariharan, Malini; Viswanathan, Prema // Asian Chemical News;10/24/2005, Vol. 11 Issue 511, p8 

    Focuses on the decision of Jubilant Organosys to increase its share of the pharmaceuticals and life sciences sector in India in 2005. Performance of the pharmaceuticals and life sciences sector in the financial year ended March 31, 2005; Merger and acquisition activities of the company;...

  • Jubilant bags manufacturing contracts worth $40m.  // Chemical Business;Feb2006, Vol. 20 Issue 2, p78 

    Reports on the contracts received by chemical firm Jubilant Organosys Ltd. from pharmaceutical and agro-chemical companies for custom manufacturing of intermediates and fine chemicals in India in 2006. Annual contracts signed by the firm for 2007; Statements issued by chairmen and managing...

  • Jubilant signs $60-m global contracts.  // Chemical Business;Apr2007, Vol. 21 Issue 4, p63 

    The article reports on international contracts worth $60 million signed by Indian integrated pharmaceuticals and large custom research and manufacturing company Jubilant Organosys in 2007. The contracts were finalized with several leading international life science firms. Chairman and managing...

  • pharmaceuticals & fine chemicals.  // Chemical Week;5/3/2006, Vol. 168 Issue 15, p22 

    The article presents news briefs on the pharmaceuticals and fine chemicals sectors as of May 3, 2006. Pharmaceutical and fine chemicals firm Jubilant Organosys says its board has approved a proposal to raise funds to fund acquisitions and capital investment projects. Biopharmaceutical and...

  • Indian Firms Record Extraordinary Growth. Ramesh, Deepti // Chemical Week;1/31/2007, Vol. 169 Issue 4, p21 

    The article reports on the financial performance of Indian pharmaceutical and fine chemical companies in 2006. India's largest pharma company, Ranbaxy Laboratories, has recorded a doubling of net profit to $117 million in 2006, on sales up 17%, to $1.36 billion. Another top pharma company,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics